Nick Mark MD Profile picture
Intensivist | Husband, Dad² | created the #1 critical care podcast @CritCareTime & infographic site @OnePagerICU | passionate about MedEd & MedTech innovation

Jul 24, 2020, 6 tweets

Here's another #Pulmonary teaching case: #FOAMed

A middle aged woman presents with many months of pleuritic chest pain and dyspnea. PFTs and CXR are shown (current CXR on right, prior from 5 yrs ago on left). DLCO is normal. HRCT shows no parenchymal lung disease.
1/

Which of the following co-morbid conditions might explain the abnormal CXR and PFT findings:

2/

Shrinking Lung Syndrome (SLS) is a rare complication of SLE or occasionally other #autoimmune/#rheumatologic conditions.

SLS is characterized by a triad of dyspnea, pleuritic chest pain, & progressive decrease in lung volumes w/o interstitial disease.

Here are her serologies
3/

First described in 1965, SLS is thought to be caused by repeated episodes of pleuritis causing limited muscle engagement and reduced inflation, leading to a progressive decrease in lung volumes and compliance.

4/

The prognosis of Shrinking Lung Syndrome (SLS) is good. Most patients respond favorably to a course of glucocorticoids (typically 40-60mg prednisone daily), with lung function & imaging often returning (almost) to baseline.

Well illustrated by this case:
5/

To summarize what we’ve learned about SLS:
* occurs in <1% of pts with SLE (rarely other rheum conditions)
* characterized by pleuritic chest pain, dyspnea, & decreased lung volumes w/ normal parenchyma
* due to repeated episodes of pleuritis
* is usually steroid responsive

6/

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling